Japanese Pharmaceuticals & Biotech Top Dividend Payers

Takeda Pharmaceutical

Market Cap: JP¥8.4t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Kissei Pharmaceutical

Market Cap: JP¥191.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Santen Pharmaceutical

Market Cap: JP¥522.7b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Tsumura

Market Cap: JP¥301.8b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥38.9b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Fuji Pharma

Market Cap: JP¥45.9b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Astena Holdings

Market Cap: JP¥19.1b

Manufactures and sells medicine-related products in Japan.

Zeria Pharmaceutical

Market Cap: JP¥90.6b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Linical

Market Cap: JP¥6.9b

A global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide.

Eisai

Market Cap: JP¥1.2t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.

Nippon Shinyaku

Market Cap: JP¥346.6b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Astellas Pharma

Market Cap: JP¥3.9t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥65.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Kaken Pharmaceutical

Market Cap: JP¥154.5b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.